JPS55147256A - 99deoxyy99methylenee5*66transsdidehydroopgf1 compound - Google Patents

99deoxyy99methylenee5*66transsdidehydroopgf1 compound

Info

Publication number
JPS55147256A
JPS55147256A JP5640880A JP5640880A JPS55147256A JP S55147256 A JPS55147256 A JP S55147256A JP 5640880 A JP5640880 A JP 5640880A JP 5640880 A JP5640880 A JP 5640880A JP S55147256 A JPS55147256 A JP S55147256A
Authority
JP
Japan
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5640880A
Other languages
English (en)
Japanese (ja)
Inventor
Reonarudo Bandeii Goodon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS55147256A publication Critical patent/JPS55147256A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP5640880A 1979-05-01 1980-04-30 99deoxyy99methylenee5*66transsdidehydroopgf1 compound Pending JPS55147256A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/035,144 US4220796A (en) 1979-05-01 1979-05-01 9-Deoxy-9-methylene-5,6-didehydro-PGF1 compounds

Publications (1)

Publication Number Publication Date
JPS55147256A true JPS55147256A (en) 1980-11-17

Family

ID=21880926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5640880A Pending JPS55147256A (en) 1979-05-01 1980-04-30 99deoxyy99methylenee5*66transsdidehydroopgf1 compound

Country Status (7)

Country Link
US (1) US4220796A (enExample)
JP (1) JPS55147256A (enExample)
BE (1) BE883071A (enExample)
DE (1) DE3016559A1 (enExample)
FR (1) FR2455579A1 (enExample)
GB (1) GB2048873B (enExample)
NL (1) NL8002356A (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016184A (en) 1975-09-17 1977-04-05 The Upjohn Company 9-Deoxy-9,10-didehydro-PGD1 compounds
US4060534A (en) * 1976-01-23 1977-11-29 The Upjohn Company 9-Deoxy-9-methylene-PGF compounds
US4165436A (en) * 1978-04-05 1979-08-21 The Upjohn Company Trans-2,3-didehydro-9-deoxy-9-methylene-PGF compounds

Also Published As

Publication number Publication date
DE3016559A1 (de) 1980-11-13
NL8002356A (nl) 1980-11-04
BE883071A (fr) 1980-10-30
FR2455579A1 (fr) 1980-11-28
US4220796A (en) 1980-09-02
GB2048873A (en) 1980-12-17
FR2455579B1 (enExample) 1984-01-27
GB2048873B (en) 1983-05-25

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
JPS55124743A (en) 99aminoalkylfluorene compound
JPS55143971A (en) 144methoxymorphinann66one compound
JPS55111255A (en) Compound structure
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS55136288A (en) Betaalactam contained compound
JPS567790A (en) Novel penicillinn1*11dioxide compound
JPS5667369A (en) Phthaloperinone compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
GB2047708B (en) Butyloctyl-magnesium compounds
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
ZA802765B (en) Novel compounds
JPS55136264A (en) Pyridineacetoamide compound
ZA807948B (en) 2-oxybenzimidazoline compounds
IL61133A0 (en) 6-methylene-morphinan compounds
JPS55124648A (en) Compound structure
JPS55147293A (en) Novel thiazolinoazetidinone compound
GB2111983B (en) Cyclopent-4-en-5-olone compounds
JPS5632575A (en) Antiifreeze compound
JPS56100858A (en) Halootriazinyl compound